88% of Companies Set Modernization Plans in Motion Within Three Years ...
Personalized iPSC-derived dopaminergic neuron therapy shows early signs of safety and potential benefit in first-in-human study...
DelveInsight forecasts an 8% CAGR from 2025 to 2034, driven by improved diagnostics and expanding treatment options....
Survey reveals strong public and professional confidence in digital health technologies to drive personalized treatment, surgical precision, and medical training across Europe....
Under Montag’s leadership, the company reports 6.8% revenue growth and a 16.6% EBIT margin, while widening EPS guidance to address rising geopolitical and trade-related risks. ...
Phase II ADVANTAGE AF trial shows 73.4% freedom from arrhythmias and high safety profile, supporting expanded use of FARAWAVE and FARAPOINT PFA catheters in treating complex AF cases....
In partnership with Frontier Psychiatry, the study reveals lower hospitalization rates and stable costs for telepsychiatry patients—validating the role of data-driven insights in value-based mental health care....
Study finds breast cancer patients who underwent IceCure’s minimally invasive cryoablation reported higher satisfaction, less pain, and faster recovery compared to standard surgery....
Balancing a world-class public-private healthcare model, Singapore continues to redefine efficiency with cutting-edge innovations, robust policies, and a commitment to accessible, high-quality medical care....
This blog highlights the top health tech clusters in 2024 and other areas shaping the digital health landscape, setting the stage for discussions at the JP Morgan Healthcare Conference and beyond. Let’s dive into the insights that defined the year. ...
